1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3 Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents
2.5. Assumption & Limitation
2.6. Analyst tools and models
3. Executive Summary
4. United States Remote Patient Monitoring Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Advancement/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. United States Remote Patient Monitoring Market Overview
5.1. Market Size & Forecast, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Component
5.2.1.1. Devices
5.2.1.1.1. Hemodynamic Monitoring
5.2.1.1.2. Neuromonitoring
5.2.1.1.3. Cardiac Monitoring
5.2.1.1.4. Fetal & Neonatal Monitoring
5.2.1.1.5. Respiratory Monitoring
5.2.1.1.6. Multiparameter Monitoring
5.2.1.1.7. Weight Monitoring
5.2.1.1.8. Temperature Monitoring
5.2.1.1.9. Urine output Monitoring
5.2.1.1.10. Others
5.2.1.2. Services
5.2.1.2.1. Consulting
5.2.1.2.2. System Integration and Deployment
5.2.1.2.3. Support and Maintenance
5.2.2. By Application
5.2.2.1. Cardiovascular Diseases
5.2.2.2. Diabetes
5.2.2.3. Cancer
5.2.2.4. Hypertension
5.2.2.5. Infections
5.2.2.6. Others
5.2.3. By End User
5.2.3.1. Hospitals & Specialty Clinics
5.2.3.2. Homecare Settings
5.2.3.3. Ambulatory Surgical Centers
5.2.3.4. Long Term & Acute Care Centers
5.2.3.5. Others
6. Competitive Landscape
6.1. List of Key Players and Their Offerings
6.2. Market Share Analysis, 2021
6.3. Competitive Benchmarking, By Operating Parameters
6.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
7. Impact of COVID-19 on United States Remote Patient Monitoring Market
8. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
8.1. Medtronic
8.2. Philips Healthcare
8.3. ResMed
8.4. 100-Plus
8.5. A&D Company
8.6. Abbott
8.7. AltumView Systems
8.8. BIOTRONIK
8.9. Boston Scientific
8.10. Bardy Diagnostics
8.11. Cardiomo Care
8.12. Cardiologs
8.13. Drgerwerk AG & Co. KGaA
8.14. Hoffmann-La Roche
8.15. GE Healthcare
8.16. Grand Care Systems
8.17. Honeywell International
8.18. iHealthUnifiedcare
8.19. Qardio
8.20. MedM
9. Key Strategic Recommendations
NOTE: Financial in information in case of non-listed companies will be provided as per availability
The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable